| Style | Citing Format |
|---|---|
| MLA | Emami H S, et al.. "Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages." Biotechnology Letters, vol. 48, no. 4, 2026, pp. -. |
| APA | Emami H S, Vakili B, Esmaeil N, Aucoin M G, Jahanian Najafabadi A (2026). Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages. Biotechnology Letters, 48(4), -. |
| Chicago | Emami H S, Vakili B, Esmaeil N, Aucoin M G, Jahanian Najafabadi A. "Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages." Biotechnology Letters 48, no. 4 (2026): -. |
| Harvard | Emami H S et al. (2026) 'Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages', Biotechnology Letters, 48(4), pp. -. |
| Vancouver | Emami H S, Vakili B, Esmaeil N, Aucoin M G, Jahanian Najafabadi A. Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages. Biotechnology Letters. 2026;48(4):-. |
| BibTex | @article{ author = {Emami H S and Vakili B and Esmaeil N and Aucoin M G and Jahanian Najafabadi A}, title = {Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages}, journal = {Biotechnology Letters}, volume = {48}, number = {4}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Emami H S AU - Vakili B AU - Esmaeil N AU - Aucoin M G AU - Jahanian Najafabadi A TI - Production of Mannosylated Hrsace2 by Baculovirus Expression System; the Way to Remove and Redirect Sars-Cov-2 Viral Particles to Macrophages JO - Biotechnology Letters VL - 48 IS - 4 SP - EP - PY - 2026 ER - |